Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
神经母细胞瘤患者的KIR和KIR配体基因型影响基于Dinutuximab的免疫疗法的临床疗效:来自儿童肿瘤协作组的报告
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-1767
Erbe, Amy K; Wang, Wei; Carmichael, Lakeesha; Kim, KyungMann; Mendonça, Eneida A; Song, Yiqiang; Hess, Dustin; Reville, Patrick K; London, Wendy B; Naranjo, Arlene; Hank, Jacquelyn A; Diccianni, Mitchell B; Reisfeld, Ralph A; Gillies, Stephen D; Matthay, Katherine K; Cohn, Susan L; Hogarty, Michael D; Maris, John M; Park, Julie R; Ozkaynak, M Fevzi; Gilman, Andrew L; Yu, Alice L; Sondel, Paul M